ES8403108A1 - Un procedimiento para preparar azetidinas. - Google Patents

Un procedimiento para preparar azetidinas.

Info

Publication number
ES8403108A1
ES8403108A1 ES518758A ES518758A ES8403108A1 ES 8403108 A1 ES8403108 A1 ES 8403108A1 ES 518758 A ES518758 A ES 518758A ES 518758 A ES518758 A ES 518758A ES 8403108 A1 ES8403108 A1 ES 8403108A1
Authority
ES
Spain
Prior art keywords
hydrogen
acilo
already mentioned
general formula
aminocarbonylaminosulfonylaminocarbonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES518758A
Other languages
English (en)
Other versions
ES518758A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of ES8403108A1 publication Critical patent/ES8403108A1/es
Publication of ES518758A0 publication Critical patent/ES518758A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR AZETIDINAS, DE FORMULA GENERAL (I), EN LA QUE R1 ES ACILO, HIDROGENO O UN GRUPO PROTECTOR DE AMINO; R2 ES HIDROGENO O METOXI; R3 Y R4 SON IGUALES O DIFERENTES Y CADA UNO DE ELLOS ES HIDROGENO, ALCOHILO O ALQUINILO.CONSISTE EN HACER REACCIONAR UNA B-LACTAMA DE FORMULA (II), EN LA QUE R2, R3 Y R4 TIENEN EL SIGNIFICADO YA MENCIONADO; Y RK1 ES ACILO, CON UN ISOCIANATO DE FORMULA GENERAL (III), EN LA QUE R5 Y R6 TIENEN LOS SIGNIFICADOS YA MENCIONADOS; Y RK1-NH- ES UN GRUPO AMINO PROTEGIDO.DE APLICACION COMO AGENTESPARA COMBATIR LAS INFECCIONES BACTERIANAS EN LOS MAMIFEROS INCLUIDOS LOS SERES HUMANOS.
ES518758A 1982-01-04 1983-01-03 Un procedimiento para preparar azetidinas. Granted ES518758A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33653782A 1982-01-04 1982-01-04
US36860982A 1982-04-15 1982-04-15

Publications (2)

Publication Number Publication Date
ES8403108A1 true ES8403108A1 (es) 1984-03-01
ES518758A0 ES518758A0 (es) 1984-03-01

Family

ID=26990250

Family Applications (1)

Application Number Title Priority Date Filing Date
ES518758A Granted ES518758A0 (es) 1982-01-04 1983-01-03 Un procedimiento para preparar azetidinas.

Country Status (19)

Country Link
EP (1) EP0085291B1 (es)
JP (1) JPS58121269A (es)
KR (1) KR890000418B1 (es)
AU (1) AU570912B2 (es)
CA (1) CA1272726C (es)
DD (1) DD207907A5 (es)
DE (1) DE3377712D1 (es)
DK (1) DK583A (es)
ES (1) ES518758A0 (es)
FI (1) FI830017L (es)
GR (1) GR77135B (es)
HU (1) HU188986B (es)
IE (1) IE54388B1 (es)
IL (1) IL67528A (es)
NO (1) NO830003L (es)
NZ (1) NZ202891A (es)
PH (1) PH21695A (es)
PT (1) PT76064A (es)
SU (1) SU1391496A3 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0117053A1 (en) * 1983-02-10 1984-08-29 Ajinomoto Co., Inc. Azetidinone derivatives
US4534896A (en) * 1983-06-13 1985-08-13 E. R. Squibb & Sons, Inc. 3-Acylamino-2-oxoazetidine-1-(β-oxopropionic acid)
US4576749A (en) * 1983-10-03 1986-03-18 E. R. Squibb & Sons, Inc. 3-Acylamino-1-carboxymethylaminocarbonyl-2-azetidinones
EG18314A (en) * 1985-09-26 1993-02-28 Squibb & Sons Inc Process for preparing of 2-oxo-1((substituted sulfonyl)amino)carbonyl)-azitidines
JPH01502660A (ja) * 1986-05-23 1989-09-14 ジ・アップジョン・カンパニー Ｎ―１置換スルホニルアミノカルボニル、ｃ―４置換モノバクタム類
US4801705A (en) * 1986-06-23 1989-01-31 E. R. Squibb & Sons, Inc. 2-oxo-1-(((substituted sulfonyl)amino)-carbonyl)azetidines
US5006650A (en) * 1987-02-11 1991-04-09 The Upjohn Company Novel N-1 substituted beta-lactams as antibiotics
US5001235A (en) * 1987-02-27 1991-03-19 The Upjohn Company Antibiotic beta-lactams containing a pyridone carboxylic acid or acid derivative
CA1317298C (en) * 1987-03-03 1993-05-04 Upjohn Company (The) Antibiotic sulfonylaminocarbonyl activated .beta.-lactams
US5015737A (en) * 1987-07-22 1991-05-14 The Upjohn Company Therapeutically useful beta-lactams
EP0344707A3 (en) * 1988-06-02 1990-04-18 E.R. Squibb & Sons, Inc. 2-Oxo-1-[[(substituted sulfonyl)-amino]carbonyl]-azetidine derivatives
MXPA04002282A (es) * 2001-09-14 2005-03-07 Axis Pharmaceutical Inc Nuevos compuestos y preparaciones como inhibidores de la catepsina.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199981A (en) * 1981-04-09 1985-08-16 Squibb & Sons Inc 2-oxo-1-(((substituted sulphonyl)amino)carbonyl)azetidines

Also Published As

Publication number Publication date
PT76064A (en) 1983-02-01
IE54388B1 (en) 1989-09-13
GR77135B (es) 1984-09-07
SU1391496A3 (ru) 1988-04-23
KR890000418B1 (ko) 1989-03-17
EP0085291A1 (en) 1983-08-10
CA1260472A (en) 1989-09-26
AU570912B2 (en) 1988-03-31
DE3377712D1 (de) 1988-09-22
FI830017A0 (fi) 1983-01-04
FI830017A7 (fi) 1983-07-05
IL67528A (en) 1986-04-29
ES518758A0 (es) 1984-03-01
PH21695A (en) 1988-01-13
NZ202891A (en) 1986-02-21
DK583A (da) 1983-07-05
AU9161782A (en) 1983-07-14
KR840002808A (ko) 1984-07-21
CA1272726C (en) 1990-08-14
HU188986B (en) 1986-05-28
EP0085291B1 (en) 1988-08-17
NO830003L (no) 1983-07-05
JPS58121269A (ja) 1983-07-19
DK583D0 (da) 1983-01-03
FI830017L (fi) 1983-07-05
DD207907A5 (de) 1984-03-21
IE823087L (en) 1983-07-04

Similar Documents

Publication Publication Date Title
ES2120535T3 (es) Agentes reticulantes con trifuncionalidad de carbamato.
ES2127946T3 (es) Antagonistas de neurocinina diazabiciclica.
MX9304756A (es) 9-[(glicilo substituido)amido]-6-desmetil-6-desoxitetraciclinas, metodo para su produccion y composiciones farmaceuticas que las contienen.
ES2153118T3 (es) Analogos heterociclicos de 1,2,4-triazolo 1,5-c)pirimidina que tienen una actividad antagonista sobre los receptores de adenosina a 2a?.
MX9700557A (es) Dihidrobenzofuranos.
ES2106783T3 (es) 1-benzopiran-4-onas y 2-amino-1,3-benzoxacin-4-onas antiarterosclerosis y antitromboticas.
AR023727A1 (es) Compuestos empleados en el tratamiento de padecimientos inflamatorios
MX9304646A (es) Nuevas 7-(sustituido)-8-(sustituido)d-9-[(glicilo sustituido)amido]-6-desmetil-6-desoxitetraciclinasy metodo para su produccion.
BG40955A3 (en) Acaricide means and method for protection from acars
ES2007318A4 (es) Compuestos de imidazol y composiciones biocidas que los comprenden.
ES8407489A1 (es) Un procedimiento para la preparacion de antibioticos de carbapenem.
ES8507491A1 (es) Un procedimiento para la preparacion de derivados de azetidina
PT1086096E (pt) Benzamidas com substituintes etra-hidrofuraniloxi como inibidores da fosfodiesterase 4
ES2084101T3 (es) Fenoxialcanol como un estabilizante para isotiazolonas.
AR025224A1 (es) Amida y guanidina oxazolidinona n-sustituida antibacteriana y metodos de uso de la misma
ES8601118A1 (es) Un procedimiento para la preparacion de nuevos derivados de carbapenem.
ES2022342B3 (es) Hidrazinas n-(opcinalmente sustituidas)-n'-sustituidas-n, n'-disustituidas, insecticidas.
ES2196069T3 (es) Derivados morfinoides condensados con heterociclos.
ATE113625T1 (de) Verfahren zur herstellung von elastischen, kompakten oder zelligen formkörpern auf der grundlage von n-substituierte harnstoff- und amidgruppen gebunden enthaltenden elastomeren, derartige elastomere und hierfür geeignete polyazomethinhaltige polyoxyalkylen-polyamin- mischungen.
ES2064159T3 (es) Derivados amidicos de los acidos glutamico, aspartico y 2-amino adipico con actividad antigastrina.
ES2152240T3 (es) Composiciones de poliuretano.
MX9102290A (es) Estereoisomeros individuales de 7-(3-1-aminoalquil)-1-pirrolidinil)-quinolonas y naftiridonas,como agentes antibacterianos
FI833101A0 (fi) Substituerade tert. -butanol-derivat, foerfarande foer deras framstaellning och dessa innehaollandeantimykotiska medel
MX9304152A (es) Inhibidores de enzimas.
ES443486A1 (es) Un procedimiento para la preparacion de compuestos antihel- minticos.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401